Quantbot Technologies LP Agenus Inc Transaction History

Quantbot Technologies LP

  • $2.36 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021
SELL
$4.98 - $6.63 $92,628 - $123,318
-18,600 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$2.56 - $5.49 $47,616 - $102,114
18,600 New
18,600 $102,000
Q3 2020

Nov 16, 2020
SELL
$2.98 - $5.2 $3,874 - $6,760
-1,300 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$2.29 - $4.24 $2,977 - $5,512
1,300 New
1,300 $5,000

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email